Cancer drug Gleevec holds promise for type 2 diabetes
Monday, March 28, 2016 - 11:20
in Health & Medicine
Stephen FellerULSAN, South Korea, March 28 (UPI) -- The cancer drug Gleevec lowered the level of insulin resistance in mice in a study, and lowered risk of hyperglycemia and obesity, without severe side effects.